Close Menu
    What's Hot

    OMP Launches Unison Express to Fast-Track Supply Chain Planning from Ambition to Early Value

    May 27, 2026

    Measles outbreak in Bangladesh passes 60,000 cases

    May 23, 2026

    UAE and Germany review strategic ties in Berlin

    May 21, 2026
    Facebook X (Twitter) Instagram
    Trending
    • OMP Launches Unison Express to Fast-Track Supply Chain Planning from Ambition to Early Value
    • Measles outbreak in Bangladesh passes 60,000 cases
    • UAE and Germany review strategic ties in Berlin
    • PM Modi and Meloni spotlight deepening India-Italy ties
    • South Korea launches $665.5 million industrial growth fund
    • Japan and South Korea launch energy security framework
    • Etihad expands Paris route with double daily A380 flights
    • GME posts strongest trading week in two decades
    • Home
    • Contact Us
    Sanaa TimesSanaa Times
    Thursday, May 28
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Sanaa TimesSanaa Times
    Home » BioMed X Launches a New Call for Application in Autoimmune Disease Research

    BioMed X Launches a New Call for Application in Autoimmune Disease Research

    November 7, 2023
    Share
    Facebook Twitter LinkedIn Pinterest Email VKontakte Telegram WhatsApp

    A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

    HEIDELBERG, GERMANY / ACCESSWIRE / November 7, 2023 / BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.

    Current therapeutic strategies for autoimmune diseases primarily focus on broadly suppressing the immune response, with significant side effects. More importantly, none of these treatments address one of the root causes of the disease, the autoreactive plasma cells that produce antibodies targeting self-antigens. By exploring the deep biology of human autoreactive plasma cells to identify biomarkers that distinguish them from their physiological counterparts, this project aims to identify new therapeutic strategies to selectively eliminate these cells in patients suffering from autoimmune diseases.

    “Immunology – including autoimmunity – is one of our R&D focus areas at our BioMed X Institutes in Heidelberg, New Haven, and our XSeed Labs in Ridgefield. Currently, we are hosting five immunology research teams at different stages of development. We are excited to extend our immunology research capabilities with this new project in the field of autoreactive plasma cells,” explains Christian Tidona, Founder and Managing Director of the BioMed X Institute.

    This new research group will be located at the BioMed X Institute in Heidelberg, Germany. Each BioMed X project is a collaboration with a leading pharmaceutical company. To learn more about this project and how to apply, visit the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C02. The deadline for applying is January 7, 2023.

    About BioMed X

    BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

    Contact Information:

    Flavia-Bianca Cristian
    Recruiting & Communications Manager
    fbc@bio.mx
    +49 6221 426 11 706

    Related Images

    SOURCE: BioMed X Institute

    View source version on accesswire.com:
    https://www.accesswire.com/800139/biomed-x-launches-a-new-call-for-application-in-autoimmune-disease-research

    Keep Reading

    OMP Launches Unison Express to Fast-Track Supply Chain Planning from Ambition to Early Value

    Tabor Redefines Anti-Drone Testing with Software-Defined SDR Platform

    Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program

    Agnete Kirk Kristiansen Appointed Chair of the LEGO Foundation

    Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services

    The White House Names Peter Arnell as U.S. Chief Brand Architect within the National Design Studio

    Editor's Pick

    Measles outbreak in Bangladesh passes 60,000 cases

    May 23, 2026

    UAE and Germany review strategic ties in Berlin

    May 21, 2026

    PM Modi and Meloni spotlight deepening India-Italy ties

    May 21, 2026

    South Korea launches $665.5 million industrial growth fund

    May 20, 2026

    Japan and South Korea launch energy security framework

    May 20, 2026

    Etihad expands Paris route with double daily A380 flights

    May 20, 2026

    GME posts strongest trading week in two decades

    May 19, 2026

    Porsche reveals bespoke 911 GT3 RS in Macadamiametallic

    May 18, 2026
    © 2026 Sanaa Times | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.